Cargando…

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer

Radiotherapy is known to influence immune function, including T cell receptor (TCR) repertoire. We evaluated the TCR repertoire before and after stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) and explored correlations between TCR indexes and distant failure afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lirong, Zhu, Jun, Rudqvist, Nils-Petter, Welsh, James, Lee, Percy, Liao, Zhongxing, Xu, Ting, Jiang, Ming, Zhu, Xiangzhi, Pan, Xuan, Li, Pansong, Zhou, Zhipeng, He, Xia, Yin, Rong, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559517/ https://www.ncbi.nlm.nih.gov/pubmed/34733273 http://dx.doi.org/10.3389/fimmu.2021.719285

Ejemplares similares

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
por: Lhuillier, Claire, et al.
Publicado: (2019)

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023)

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
por: Jing, Wang, et al.
Publicado: (2021)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

Barriers to Radiation-Induced In Situ Tumor Vaccination
por: Wennerberg, Erik, et al.
Publicado: (2017)

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
por: Dong, Baiqiang, et al.
Publicado: (2023)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer
por: Kocak Uzel, Esengul, et al.
Publicado: (2023)

CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer
por: Yang, Yan, et al.
Publicado: (2021)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020)

Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
por: Sun, Xiaojiang, et al.
Publicado: (2020)

Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma
por: Lo, Herman, et al.
Publicado: (2019)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
por: Schoenhals, Jonathan E., et al.
Publicado: (2021)

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023)

Stereotactic body radiation therapy or surgery for stage I–II non-small cell lung cancer treatment?—outcomes of a meta-analysis
por: Zhang, Qiuning, et al.
Publicado: (2019)

A hybrid planning strategy for stereotactic body radiation therapy of early stage non‐small‐cell lung cancer
por: Liu, Han, et al.
Publicado: (2018)

Stereotactic body radiation therapy for early-stage non–small-cell lung cancer in octogenarians and older: an alternative treatment
por: Bei, Yanping, et al.
Publicado: (2020)

Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
por: Kraus, K. M., et al.
Publicado: (2021)

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
por: Doupnik, Nathan P, et al.
Publicado: (2022)

Stereotactic or Conventional Radiation for Early-Stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Mutsaers, Adam, et al.
Publicado: (2023)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
por: Jing, Wang, et al.
Publicado: (2022)

Clinical Analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma
por: Wu, Dajun, et al.
Publicado: (2011)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results
por: Bijlani, Akash, et al.
Publicado: (2013)

Neoadjuvant Programmed Cell Death Protein 1 Blockade Combined With Stereotactic Body Radiation Therapy for Stage III(N2) Non-Small Cell Lung Cancer: A Case Series
por: Wang, Zhen, et al.
Publicado: (2022)

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
por: Wang, Qingjun, et al.
Publicado: (2022)

Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma
por: Jiang, Changchen, et al.
Publicado: (2021)

Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2022)

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Brooks, Eric D., et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience
por: Factor, Oren B., et al.
Publicado: (2014)

Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
por: Jumeau, Raphaël, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qt86bp97rls97etkpktk0i8pnp